We found, on the one hand, that ALKBH5 regulates JAK2 expression through m6A methylation, activating the JAK2/p-STAT3 pathway to increase PD-L1 expression and promote NSCLC progression. Here, STAT3 is linked to non-small cell lung carcinoma.